Sanofi-Aventis seeks dismissal of Lantus antitrust case
MLex Summary: Sanofi-Aventis has asked US Magistrate Judge Judith Dein to dismiss claims that it unlawfully barred market entry of a generic version of its branded long-acting insulin analogue drug Lantus....To view the full article, register now.
Already a subscriber? Click here to view full article